FRG2GP

Across TCGA pan-cancer cohorts, FRG2GP RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated FRG2GP data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher FRG2GP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FRG2GP expression acts as an unfavorable survival marker.

ACC, STAD, and KIRP are the cancer types where FRG2GP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.624	<.001	99	view →
STAD	DFS	Tertile	All	0.217	0.739	<.001	81	view →
KIRP	OS	Tertile	II,III,IV	0.148	0.771	<.001	54	view →
LGG	OS	Tertile	All	0.438	0.813	.009	33	view →
ESCA	DFS	Tertile	III,IV	0.260	0.458	.007	24	view →
THCA	OS	Tertile	IV	0.751	1.000	.014	12	view →
SKCM	DFS	Tertile	III,IV	0.118	0.647	.045	9	view →
SARC	OS	Tertile	All	0.325	0.736	.016	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

FRG2GP–ACC (DFS)

Open the ACC breakdown →